Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Short Interest Down 32.4% in December

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) was the target of a large decline in short interest in the month of December. As of December 15th, there was short interest totaling 161,309 shares, a decline of 32.4% from the November 30th total of 238,781 shares. Based on an average daily volume of 106,055 shares, the days-to-cover ratio is presently 1.5 days. Approximately 0.5% of the shares of the company are short sold. Approximately 0.5% of the shares of the company are short sold. Based on an average daily volume of 106,055 shares, the days-to-cover ratio is presently 1.5 days.

Rapid Micro Biosystems Trading Down 5.2%

RPID traded down $0.15 during trading on Tuesday, reaching $2.75. The company had a trading volume of 232,887 shares, compared to its average volume of 213,389. The firm’s 50-day simple moving average is $3.52 and its 200 day simple moving average is $3.33. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.95 and a current ratio of 4.23. The company has a market cap of $121.88 million, a price-to-earnings ratio of -2.72 and a beta of 1.33. Rapid Micro Biosystems has a 12-month low of $0.87 and a 12-month high of $4.50.

Rapid Micro Biosystems (NASDAQ:RPID) last released its earnings results on Friday, November 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.26). Rapid Micro Biosystems had a negative return on equity of 73.90% and a negative net margin of 145.11%.The company had revenue of $7.84 million during the quarter, compared to analyst estimates of $7.60 million. Equities research analysts anticipate that Rapid Micro Biosystems will post -1.1 earnings per share for the current year.

Institutional Trading of Rapid Micro Biosystems

A number of institutional investors have recently bought and sold shares of RPID. Hudson Bay Capital Management LP purchased a new position in Rapid Micro Biosystems in the third quarter valued at about $38,000. American Century Companies Inc. acquired a new position in Rapid Micro Biosystems in the first quarter worth approximately $31,000. XTX Topco Ltd bought a new position in Rapid Micro Biosystems during the second quarter valued at approximately $144,000. Dimensional Fund Advisors LP raised its position in Rapid Micro Biosystems by 37.8% during the third quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock valued at $186,000 after acquiring an additional 15,255 shares in the last quarter. Finally, Susquehanna International Group LLP lifted its stake in Rapid Micro Biosystems by 12.6% in the third quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock valued at $195,000 after acquiring an additional 6,528 shares during the last quarter. Institutional investors and hedge funds own 52.60% of the company’s stock.

Analyst Upgrades and Downgrades

RPID has been the subject of several recent analyst reports. Wall Street Zen cut shares of Rapid Micro Biosystems from a “hold” rating to a “sell” rating in a research report on Sunday. Weiss Ratings reissued a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $8.00.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.